Skip to main content

Advertisement

Log in

Anticoagulation after intracerebral hemorrhage in patients with atrial fibrillation: between Scylla and Charybdis

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

Oral anticoagulants (OAC) are indicated in patients with atrial fibrillation (AF) and high risk of ischemic stroke. However, the introduction of anticoagulation in patients with AF and previous intracerebral hemorrhage (ICH) is controversial. We aimed to better understand the efficacy and safety of OAC in this context and to assess the factors that may influence this decision.

Methods

In a single-center retrospective observational study, patients with AF and ICH who survived hospitalization at a level A Stroke Unit between 2009 and 2018 were included. Patients were followed for two years after discharge. Data were collected regarding the introduction or not of OAC and the occurrence of major thrombotic/hemorrhagic events and death.

Results

Ninety-five patients (75.2 ± 9.9 years) were included and 40 patients (42.1%) started OAC. Patients were more likely to initiate anticoagulation if they had: mechanical prosthetic valves, previous AF (p = 0.005) and previous OAC therapy (p < 0001); and less if they had previous hemorrhagic stroke (p < 0.005). During follow-up, 10.5% had at least one major hemorrhagic event (60% anticoagulated), 20% had at least one major thrombotic event (all non-anticoagulated) and 20% died. The only factor associated with the risk of bleeding was ICH score (OR:2.49 per 1-point increase; 95%CI:1.14–5.46). Patients who initiated anticoagulation had lower mortality than non-anticoagulated (OR:0.296; 95%CI:0.090–0-975). Previous ICH and higher CHA2DS2-VASc were associated with higher mortality.

Conclusion

In this retrospective series, anticoagulation reduced thrombotic events and overall mortality in patients admitted for ICH and AF, without a significant increase in bleeding risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

Data were collected after authorization from the São João University Hospital Center. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Qureshi AI, Mendelow AD, Hanley DF (2009) Intracerebral haemorrhage. Lancet (London, England) 373:1632–1644

    Article  Google Scholar 

  2. Steiner T, Al-Shahi Salman R, Beer R et al (2014) European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 9:840–855

    Article  Google Scholar 

  3. Li YG, Lip GYH (2018) Anticoagulation resumption after intracerebral hemorrhage. Curr Atheroscler Rep 20:32

    Article  Google Scholar 

  4. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ (2010) Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. The Lancet Neurology 9:167–176

    Article  Google Scholar 

  5. Ariesen MJ, Claus SP, Rinkel GJ, Algra A (2003) Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 34:2060–2065

    Article  CAS  Google Scholar 

  6. Peters SAE, Woodward M (2019) Established and novel risk factors for atrial fibrillation in women compared with men. Heart (British Cardiac Society) 105:226–234

    CAS  Google Scholar 

  7. Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962

    Article  Google Scholar 

  8. Perreault S, Cote R, White-Guay B, Dorais M, Oussaid E, Schnitzer ME (2019) Anticoagulants in older patients with nonvalvular atrial fibrillation after intracranial hemorrhage. J Stroke 21:195–206

    Article  Google Scholar 

  9. Hindricks G, Potpara T, Dagres N, et al. 2020 (2021) ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 1;42(5):373–498.

  10. Murthy SB, Gupta A, Merkler AE et al (2017) Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis. Stroke 48:1594–1600

    Article  Google Scholar 

  11. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC (2001) The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32(4):891–7

    Article  Google Scholar 

  12. Greenberg SM, Charidimou A (2018) Diagnosis of cerebral amyloid angiopathy: evolution of the Boston Criteria. Stroke 49:491–497

    Article  Google Scholar 

  13. Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151

    Article  CAS  Google Scholar 

  14. Pennlert J, Overholser R, Asplund K et al (2017) Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation. Stroke 48:314–320

    Article  Google Scholar 

  15. Nielsen PB, Larsen TB, Skjoth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY (2015) Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide cohort study. Circulation 132:517–525

    Article  CAS  Google Scholar 

  16. Raparelli V, Proietti M, Cangemi R, Lip GY, Lane DA, Basili S (2017) Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants. Thrombosis and haemostasis 117:209–18

    Article  Google Scholar 

  17. Sembill JA, Kuramatsu JB, Schwab S, Huttner HB (2019) Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage. Neurological Research and Practice 1

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carla Seabra Abrantes.

Ethics declarations

Ethical approval

The protocol was previously approved by the Ethics Committee of our Institution. Due to the retrospective nature of the study, the Ethics Committee agreed that the submission of informed consent is waived. We have these documentation that can be send in attachment.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abrantes, C.S., Pintalhão, M., Tavares, S. et al. Anticoagulation after intracerebral hemorrhage in patients with atrial fibrillation: between Scylla and Charybdis. Neurol Sci 43, 2441–2448 (2022). https://doi.org/10.1007/s10072-021-05602-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-021-05602-7

Keywords

Navigation